Amputation Risk Up for Black, Rural Residents With Diabetic Foot Ulcers

TUESDAY, April 26, 2022 (HealthDay News) -- Rural patients identifying as Black have more than a 10 percent absolute increased risk for major leg amputation or death compared with the overall cohort of adult Medicare patients hospitalized with a diabetic foot ulcer, according to a study published online April 21 in JAMA Network Open.
Meghan B. Brennan, M.D., from the University of Wisconsin in Madison, and colleagues examined the associations of race, ethnicity, rurality, and/or neighborhood disadvantage with outcomes among U.S. patients with diabetic foot ulcers. The analysis included 124,487 patients hospitalized with diabetic foot ulcers (2013 to 2014) identified through the U.S. National Medicare Claims Data Database.
The researchers found that 17.6 percent of the cohort overall, 18.3 percent of rural patients, and 21.9 percent of Black patients underwent major leg amputation or died. This percentage reached 28.0 percent among rural patients identifying as Black, which exceeded the expected excess for rural patients (0.7 percent) plus those identifying as Black (4.3 percent) by more than twofold (10.4 versus 5.0 percent). A significant interaction between race and rurality remained high in adjusted predicted probability of major leg amputation or death (24.7 percent).
"Findings support using an intersectionality lens to investigate and address disparities in major leg amputation and mortality for patients with diabetic foot ulcers," the authors write.
Related Posts
Neuroimaging Use in Ischemic Stroke Examined for Medicare Patients
MONDAY, May 2, 2022 (HealthDay News) -- From 2012 to 2019, there were...
Scientists Decode the Y Chromosome, Key to Male Development
WEDNESDAY, Aug. 23, 2023 (HealthDay News) -- An international research team has...
Abrocitinib Efficacious for Eczema, Regardless of Dupilumab Response
WEDNESDAY, May 4, 2022 (HealthDay News) -- For patients with moderate-to-severe...
Fourth COVID-19 Vaccine Dose Safe for Immunocompromised
MONDAY, July 18, 2022 (HealthDay News) -- A fourth dose of mRNA COVID-19 vaccine...